<unk> , sold under the brand name Trizivir, is a fixed-dose combination antiretroviral medication for the treatment of HIV/AIDS. It contains three reverse transcriptase inhibitors patented by GlaxoSmithKline and marketed by a joint venture with Pfizer, ViiV Healthcare: *<unk>  sulfate (ABC) * lamivudine (3TC) * zidovudine (AZT or ZDV) It is indicated in the treatment of AIDS/HIV-1. For this purpose, the combination is very useful in pregnant women to decrease the risk of mother-to-child transmission. The most common effects include headache and nausea (feeling sick).<unk>  was approved for use in the United States and the European Union in 2000. In December 2013, Lupin Limited launched a generic version of<unk> .
Abacavir/lamivudine/zidovudine
Lamivudine/tenofovir
Doravirine/lamivudine/tenofovir
Lamivudine/zidovudine
Lamivudine/nevirapine/zidovudine
Atazanavir/ritonavir
Dolutegravir/lamivudine/tenofovir
Efavirenz/lamivudine/tenofovir